SOT for Viruses

Pipeline

At Welmedis, we focus on identifying groups of cancer patients with limited effective treatment options and developing targeted therapies tailored to their specific cancer profiles. Our pipeline showcases ongoing research and development projects, highlighting their current status and field of indication.

Our Pipeline at Welmedis

Target / Program

Undisclosed II

Indication: Cancer therapy

Validation

Target / Program

Undisclosed I

Indication: Cancer therapy

Preclinical

Target / Program

Phospholipid kinase

Indication: Cancer therapy

Preclinical